Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.050
+0.080 (8.26%)
At close: Jun 6, 2025, 4:00 PM
1.090
+0.040 (3.80%)
After-hours: Jun 6, 2025, 7:10 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $75.14 million as of June 6, 2025. Its market cap has increased by 2.02% in one year.
Market Cap
75.14M
Enterprise Value
78.94M
1-Year Change
2.02%
Ranking
Category
Stock Price
1.05
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $75.14M, a decrease of -16.71%. That is a compound annual growth rate of -7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 75.14M | -8.69% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |